...
首页> 外文期刊>Cellular Signalling >Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation
【24h】

Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation

机译:蛋白磷酸酶2A羧甲基化和调节性B亚基差异调节肥大细胞脱粒

获取原文
获取原文并翻译 | 示例
           

摘要

Asthma is characterised by antigen-mediated mast cell degranulation resulting in secretion of inflammatory mediators. Protein phosphatase 2A (PP2A) is a serine/threonine protein phosphatase composed of a catalytic (PP2A-C) subunit together with a core scaffold (PP2A-A) subunit and a variable, regulatory (PP2A-B) subunit. Previous studies utilising pharmacological inhibition of protein phosphatases have suggested a positive regulatory role for PP2A in mast cell degranulation. In support of this we find that a high okadaic acid concentration (1. μM) inhibits mast cell degranulation. Strikingly, we now show that a low concentration of okadaic acid (0.1 μM) has the opposite effect, resulting in enhanced degranulation. Selective downregulation of the PP2A-Cα subunit by short hairpin RNA also enhanced degranulation of RBL-2H3 mast cells, suggesting that the primary role of PP2A is to negatively regulate degranulation. PP2A-B subunits are responsible for substrate specificity, and carboxymethylation of the PP2A-C subunit alters B subunit binding. We show here that carboxymethylation of PP2A-C is dynamically altered during degranulation and inhibition of methylation decreases degranulation. Moreover downregulation of the PP2A-Bα subunit resulted in decreased MK2 phosphorylation and degranulation, whilst downregulation of the PP2A-B'δ subunit enhanced p38 MAPK phosphorylation and degranulation. Taken together these data show that PP2A is both a positive and negative regulator of mast cell degranulation, and this differential role is regulated by carboxymethylation and specific PP2A-B subunit binding.
机译:哮喘的特征是抗原介导的肥大细胞脱粒,导致炎症介质的分泌。蛋白磷酸酶2A(PP2A)是一种丝氨酸/苏氨酸蛋白磷酸酶,由催化(PP2A-C)亚基,核心支架(PP2A-A)亚基和可变的调节性(PP2A-B)亚基组成。先前利用蛋白质磷酸酶的药理学抑制作用的研究表明,PP2A在肥大细胞脱粒中具有积极的调节作用。为了证明这一点,我们发现高冈田酸浓度(1.μM)抑制肥大细胞脱粒。令人惊讶的是,我们现在显示低浓度的冈田酸(0.1μM)具有相反的作用,导致脱粒作用增强。短发夹RNA对PP2A-Cα亚基的选择性下调也增强了RBL-2H3肥大细胞的脱颗粒,这表明PP2A的主要作用是负调节脱颗粒。 PP2A-B亚基负责底物特异性,PP2A-C亚基的羧甲基化可改变B亚基的结合。我们在这里显示,PP2A-C的羧甲基化在脱粒过程中动态变化,抑制甲基化会降低脱粒作用。此外,PP2A-Bα亚基的下调导致MK2磷酸化和脱粒减少,而PP2A-B'δ亚基的下调增强了p38 MAPK磷酸化和脱粒。这些数据加在一起表明,PP2A既是肥大细胞脱粒的正调节剂,也是肥大细胞脱颗粒的负调节剂,这种差异作用受羧甲基化和特定PP2A-B亚基结合的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号